Navigation Links
Butter-flavored popcorn ingredient suspected cause of lung disease
Date:4/30/2008

Los Angeles, London, New Delhi, and Singapore (April 29, 2008) An unusually high incidence of lung disease has been diagnosed in workers at popcorn factories. Researchers are focusing on diacetyl, the ingredient which is largely responsible for the odor and flavor of the butter in popcorn, according to an article published by SAGE in the current issue of Toxicologic Pathology.

Workers making microwave popcorn and flavoring chemicals are at increased risk for developing lung disease, said lead researcher, Ann Hubbs of the Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, (NIOSH), Centers for Disease Control and Prevention in Morgantown, WV.. This research, in conjunction with other recent studies, supports the conclusion that diacetyl is an inhalation hazard and further studies are needed to also investigate other agents in butter flavoring so we have the information needed to protect workers.

The study examined diacetyl and its health consequences. Diacetyl is easily vaporized at temperatures used in microwave popcorn production, which results in high concentrations in the workplace.

The NIOSH research examined the acute toxicity of inhaled diacetyl in rats, and compared different exposure patterns. It was one of the very first studies to evaluate the respiratory toxicity of the chemical flavoring agent at levels relevant to human health. The researchers found that diacetyl including just its vapors can injure lungs.


'/>"/>

Contact: Jim Gilden
media.relations@sagepub.com
SAGE Publications
Source:Eurekalert

Page: 1

Related biology news :

1. Popcorn-ball design doubles efficiency of dye-sensitized solar cells
2. Researchers close in on origins of main ingredient of Alzheimers plaques
3. USP awards verified mark to Dr. Reddys Laboratories, Ltd. ingredients
4. Cause and affect: Emotions can be unconsciously and subliminally evoked, study shows
5. Kids with autism may have gene that causes muscle weakness
6. A genetic cause for iron deficiency
7. Changes in ocean conditions in Sargasso Sea potential cause for decline in eel fishery
8. Unfavorable ocean conditions likely cause of low 2007 salmon returns along West Coast
9. Scientists discover how cigarette smoke causes cancer: Study points to new treatments, safer tobacco
10. Moderate prenatal exposure to alcohol and stress in monkeys can cause touch sensitivity
11. Why serotonin can cause depression and anxiety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... 22, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... and Life Sciences Awards as "Most Outstanding in ... unprecedented year of recognition and growth for MedNet, which ... years. iMedNet ™ , MedNet,s ...
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... December 05, 2016 , ... The Real Dirt ... premier cannabis technology and application experts, Chip Baker. Chip Baker formerly co-founded Royal ... the past 30 years, Chip Baker other industry veterans have made the evolution ...
(Date:12/5/2016)... CHICAGO , December 5, 2016 ... report, "Cell Expansion Market, by Products (Consumable, Instruments, ... Applications (Regenerative Medicine and Stem Cell Research, Cancer, ... Research Institutes, Cell Banks) - Global Revenue, Trends, ... by Scalar Market Research, the global cell expansion ...
(Date:12/5/2016)... - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) ... Monitoring Board (DSMB) for the Company,s Phase 3 ... has completed a second planned safety review and ... without any modifications. The DSMB reviewed available study ... concerns were identified. The DSMB will conduct additional ...
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
Breaking Biology Technology: